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Abstract 
 
OBJECTIVE: The objective of this selective EBM review is to determine whether or not the 
substances found in green tea are effective in reducing noninflammatory and inflammatory lesion 
counts in men and women with acne vulgaris. 
 
STUDY DESIGN: Systemic review of two double-blind RCTs and one case study published 
after 2008, all in the English language. 
 
DATA SOURCES: Data sources obtained for this review were found using PubMed, published 
in peer-reviewed journals and selected based on relevance to the clinical question, outcomes 
measured and date published. 
 
OUTCOMES MEASURED: The outcomes were measured based off of reduction in total lesion 
counts, patient satisfaction (defined as full satisfaction, partial satisfaction or no satisfaction), 
and a Leeds score which is a common, objective technique used by dermatologists to assess 
inflammatory and noninflammatory acne lesions.  
 
RESULTS: All three studies showed significance in decreasing total lesion counts with the use 
of green tea products. Yoon et al. showed statistical significance between each epigallocatechin-
3-gallate (EGCG) treated group and baseline, and statistical significance between each EGCG-
treated group and control. In Lu et al. green tea extract significantly reduced lesion counts on the 
nose, perioral area and the chin with a P<0.05. Additionally, in Elsaie et al. the decrease in total 
lesion counts was also statistically significant with a P<0.0001 after use of a topical green tea 
lotion. 
 
CONCLUSIONS: The use of the anti-inflammatory polyphenol epigallocatechin-3-gallate in 
green tea could be a potential low-cost, natural alternative medicine for the treatment of acne. 
 
KEY WORDS: acne vulgaris, green tea, epigallocatechin-3-gallate (EGCG) 
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INTRODUCTION 
 
 Acne vulgaris is defined as a chronic inflammatory disease of the pilosebaceous units 
characterized by erythematous papules, pustules and comedones, and which can eventually lead 
to scarring.1 It is the most common skin disorder affecting adolescents and young adults with a 
prevalence ranging from 35% to over 90% and it can persist past the third decade.2 In 2013 it was 
estimated that 5.1 million Americans sought treatment for acne vulgaris and $400 million were 
lost in productivity for patients and caregivers.3 On top of the financial burden this condition 
holds upon the country, acne has shown to cause significant psychological and social effects of 
embarrassment, anxiety and insecurity, as well as physical effects in terms of  life-long scarring 
and disfiguration.4 Therefore, it is of utmost importance that clinicians are well versed in finding 
the most effective treatments for each individual patient for the sake of the person suffering as 
well as for the financial burden the condition takes on the country. 
 The four main factors involved in the pathophysiology of acne are: follicular 
hyperkeratinization, increased sebum production, Propionbacterium acnes within the follicle, 
and inflammation.2 During the prepubertal period, there is a significant increase in sebum as the 
sebaceous glands enlarge; this sebum creates a medium of growth for P. acnes causing the 
bacteria to thrive.2 There are also multiple external factors which play a role in the development 
and persistence of acne such as family history, diet, stress, insulin resistance and BMI. Studies 
have shown that 85% of adolescents in the US are affected by acne.4 Though much progress has 
been made throughout the past decade in terms of discovering the physiological process behind 
acne, the interactions between them are complex. Additionally, many of the treatments available 
only have modest efficacy and do not always target all four factors of acne development.  
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 First line medications for acne treatment typically include topical medications such as 
retinoids, benzyl peroxide, and salicylic acid.5 These medications are best for mild acne and take 
four to eight weeks to see improvement but have been shown to cause burning and irritation.4,5 
Antibiotics such as tetracyclines can be prescribed to reduce inflammation and as a bacterostatic, 
which stops bacteria from reproducing, but this treatment poses a risk for antibiotic resistance 
and gastrointestinal side effects.5 Isotretinoin and hormonal therapies are the only treatments that 
decrease sebum production.4 Although effective, isotretinoin comes with the risk of 
teratogenicity, dyslipidemia and liver damage, and needs to be highly monitored throughout its 
course.4 Hormonal therapy, such as birth control pills, is a good option in some young women 
but not an option in males.  
 It is clear that there is still more research to be done in finding more effective, less costly 
treatments with minimal side effects for acne vulgaris. With a rapid increase in complementary, 
alternative medicine in Western countries, the major polyphenol epigallocatechin-3-gallate 
(EGCG) found in green tea has received increased attention. Epigallocatechin-3-gallate has been 
shown to have potent antimicrobial, anticarcogenic, and anti-inflammatory properties as well as 
the ability to modulate the production and actions of androgens and other hormones.1,4 
Therefore, green tea, a cost-effective, more generally safe, natural substance could potentially 
play a role in decreasing and treating acne vulgaris. This systematic review evaluates two double 
blind RCTs (randomized controlled trials) and one case study to determine if the EGCG in green 
tea can effectively reduce lesion counts in men and women with acne vulgaris. 
OBJECTIVE 
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The objective of this selective EBM review is to determine if the substances found in 
green tea are effective in reducing inflammatory and noninflammatory lesion counts in men and 
women with acne vulgaris. 
METHODS 
 Two double-blind, randomized control trials and one case study were selected for this 
systemic review. Criteria for their selection included their relevance to the clinical question, 
population studied and outcomes measured in patient-oriented results. Each study chosen 
evaluated the efficacy of green tea and its polyphenol EGCG in reducing lesion counts of men 
and women aged 15-45 with acne vulgaris.  The subjects in Ji et al. were treated with 1% or 5% 
EGCG solution on one half of their face twice per day for eight weeks, while the subjects in Lu 
et al. had a daily dose of oral EGCG for four weeks.4,6 Lastly in Elsaie et al. 2% green tea lotion 
with ethanol was applied on lesions twice daily for six weeks.1 Effectiveness was determined 
through total lesion counts in all trials and also through patient satisfaction. 
 “Acne vulgaris”, “green tea” and “epigallocatechin-3-gallate” were the keywords used to 
search for double-blinded RCTs published in peer-reviewed journals via PubMed. All studies 
were published in English within the past 10 years, after 2008. Cochrane systemic reviews were 
excluded as well as studies in which the patients did not have a clinical diagnosis of acne 
vulgaris. If the study’s results were not applicable to patient outcomes, they were additionally 
exempt from the systemic review. In the Lu et al. study, women who had systemic retinoid or 
hormone treatment in the past three months and/or women who had a systemic disease or 
dermatologic condition that could skew results were excluded from the study.6 Table 1 
demonstrates the demographics and characteristics of the selected reviewed studies. Statistics 
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used to evaluate efficacy of the treatment included the p value and numbers needed to harm, 
NNH. 
Table 1: Demographics and characteristics of included studies 
Study Type # of Pts Age 
(Yrs) 
Inclusion 
Criteria 
Exclusion 
criteria 
W/D Interventions 
Elsaie, 
20091 
Case 
Study 
20 15-36 Men and 
women with 
mild to 
moderate acne 
vulgaris who 
were 
outpatients in 
a Dermatology 
National 
Research 
Centre clinic  
Not listed in 
article  
0 2% green tea 
lotion (100ml) 
with ethanol 
(25ml) applied 
x2 daily for 6 
weeks  
Ji, 20134 Double 
blind, 
split 
faced 
RCT 
37 Mean 
age 
22.1 
Men and 
women with 
mild to severe 
facial acne 
vulgaris 
Not listed in 
article 
2 1% or 5% 
EGCG 
solution (the 
major 
polyphenol in 
green tea) on 
one side of 
face (chosen 
randomly) x2 
per day for 8 
weeks 
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Table 1: Demographics and characteristics of included studies 
Study Type # of Pts Age 
(Yrs) 
Inclusion 
Criteria 
Exclusion 
criteria 
W/D Interventions 
Lu, 
20166 
Double 
blind 
RCT 
80 25-45 Women aged 
25-45 years 
old with 
moderate-
severe acne 
vulgaris  
Women who 
had systemic 
retinoid or 
hormone 
treatment in the 
past 3 months 
and/or women 
who had a 
systemic 
disease or 
dermatologic 
condition that 
could skew 
results 
16 1 
decaffeinated 
green tea 
extract capsule 
30 minutes 
after a meal 
daily for 4 
weeks 
 
OUTCOMES MEASURED 
 The common outcome measured in all three studies was the total lesion counts on the 
patients. In Elsaie et al. a total lesion count (TLC) of all patients in the trial was taken by adding 
together the papules and pustules on the patients’ faces. A severity index (SI) was also created 
through the total lesion counts, <10 lesion was given an SI of 1, 10-20 lesions was given an SI of 
2, and >20 lesions was given an SI of 3. These outcomes were measured every two weeks after 
the start to the end of the trial at six weeks.  
 In Ji et al. a revised Leeds score was used to calculate total number of lesions. The Leeds 
score takes into account inflammatory lesions, such as papules, nodules, pustules and cysts, as 
well as noninflammatory lesions, such as comedones. Ji et al. also used a visual analogue score 
(VAS) to analyze patients' subjective assessments of their acne. At the beginning of the study 
each patient’s VAS was a 10 and they subjectively judged the severity of their acne and whether 
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it was improving or worsening through the eight weeks. Leeds score and VAS were taken every 
two weeks of the eight-week trial.4 
 Lastly, in Lu et al. total lesion counts (including inflammatory and noninflammatory 
lesions) were recorded on each patient in the trial by dermatologists who did not know which 
patients were in the experimental group or control at baseline and after four weeks.6 
RESULTS 
 For this systemic review two randomized double-blind trials and one clinical trial were 
selected to determine the efficacy of substances from green tea in decreasing lesions counts in 
patients with acne vulgaris. All three studies used data based off of an intention-to-treat analysis. 
The analysis of outcomes is based off of improvement in inflammatory and noninflammatory 
lesions from acne vulgaris.  
In Elsaie et al. 20 patients (6 males, 14 females) were enrolled in the study between the 
ages of 15-36 with mild to moderate acne vulgaris. They were all currently outpatients at the 
same dermatology clinic. Patients enrolled were instructed to apply 2% green tea lotion which 
was crafted with 100ml of brewed green tea, plus 25ml of ethanol for preservation, twice daily to 
the face for six weeks. No patients withdrew from the study. Student t-tests were used to 
determine significance. At baseline, the mean TLC was 24 and at the end of the six weeks the 
mean TLC was 10, a reduction of 58.33%, with statistically significant p value <0.0001 and a 
confidence interval (CI) of 8.58-19.42. The mean severity index (SI) also decreased after the six-
week trial from 2.05 to 1.25, a 39.02% decrease with a statistically significant p value <0.0001 
and a CI of 0.54-1.26. 3 of 20 (15%). 2 out of 20 patients complained of mild pruritus that 
developed at baseline and lasted three days. Clinical visits occurred every two weeks after 
baseline for eight weeks. A Wilcoxon signed-rank test was used to determine significance. The 
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mean revised Leeds score at baseline was 5.1; after eight weeks patients (10%) complained of 
stinging the first day of the study which resolved within 48 hours. 
In Ji et al.’s study, 35 of the of 37 patients enrolled completed the eight-week study. The 
mean age of the patients was 22.1 with 17 males and 18 women. A side of each patient's face 
was randomly selected to receive either 1% or 5% EGCG solution. The opposite side of their 
face was then blindly given the control of 3% ethanol. With the 1% or 5% EGCG applied to the 
selected side of the face, the mean Leeds score significantly declined to 1.2 and 1.7, respectively 
by the end of the study. Noninflammatory lesions decreased from 53.8 to 15.6 and inflammatory 
lesions decreased from 10.0 to 1.1 with 1% EGCG which a is a 79% and 89% reduction 
respectively. The VAS scores were also significantly reduced from 10 to 3.5 with the 1% EGCG 
and from 10 to 4.9 in the 5% EGCG. In terms of numbers needed to harm (NNH) with every four 
persons treated with EGCG, one additional person will experience mild erythema or irritation. 
In Lu et al. 80 women between the ages of 25-45 with moderate to severe acne were 
enrolled in the study and 64 completed the four-week intervention. Women who had systemic 
retinoid or hormone treatment in the past 3 months and/or women who had a systemic disease or 
dermatologic condition that could skew results were exempt from the study. Using computed 
randomization subjects, half were chosen to take one decaffeinated 500 mg green tea extract 
capsule, while the other half were given the placebo, pure microcrystalline cellulose capsules. 
Everyone was told to take a capsule 30 minutes after a meal daily for 4 weeks. BMI, hip and 
waist circumference, blood pressure, fasting glucose, and lipid profiles were also taken into 
account throughout the study and there were no significant differences between the control and 
experimental groups. Using paired t-tests, acne lesion counts on the nose, perioral area and chin 
significantly decreased with p values of 0.03, 0.04, and 0.03 respectively. Total inflammatory, 
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forehead, cheek, whole face and total non-inflammatory lesions did not significantly decrease all 
with p values >0.05 after treatment. 
Table 2: Mean TLC and SI from baseline to 6 weeks1 
 Baseline After 6 weeks % Reduction P value 
Mean TLC 24 10 58.33 <0.0001* 
Mean SI 2.05 1.25 39.02 <0.0001* 
 
*Signifies statistical significance (p<0.05) 
Table 3: Mean Revised Leeds and VAS scores before and after treatment4 
 Baseline After 8 weeks 
Mean Revised Leeds Score   
1% ECGC 5.2 1.2 
5% EGCG 5.2 1.7 
Mean VAS score   
1% 10 3.5 
5% 10 4.9 
 
 
Table 4: P values of acne lesion counts after 4 weeks of oral green tea extract6 
Acne lesion counts P values 
Inflammatory 0.68 
Forehead 0.76 
Cheek 0.03* 
Nose 0.04* 
Perioral Area 0.03* 
Chin 0.88 
Whole face 0.41 
Non-inflammatory 0.80 
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Table 3: Mean Revised Leeds and VAS scores before and after treatment4 
 Baseline After 8 weeks 
Total 0.83 
 
 *Signifies statistical significance (p<0.05) 
Safety and Tolerability 
 In all three trials no major adverse side effects were reported and no subjects withdrew 
due to intolerability. In Elsaie et al. three out of twenty patients complained of mild pruritus 
lasting from the first day of application to day three, and two out of 20 patients complained of a 
mild stinging after first applying the lotion which lasted less than 48 hours. In Ji et al. NNH of 
four shows that one in every four patients will experience minimal irritation and stinging. In Lu 
et al. one subject developed mild constipation while two subjects complained of abdominal 
discomfort. 
DISCUSSION 
 Based on the two double-blinded RCTs and one case study reviewed, green tea and the 
active substance within, EGCG, can significantly reduce lesion counts in males and females with 
acne vulgaris. However, these studies do have their limitations. In Lu et al. significance was not 
shown for total inflammatory and noninflammatory lesion counts and only showed significance 
for the nose, chin and perioral region. Hypotheses of why this study may not have had as much 
success include the way the green tea was administered, the population being studied, and the 
length of the trial. Starting off, this study was the only one in which the green tea byproduct was 
not used topically but administered orally through a capsule. Perhaps green tea is most potent 
when applied directly to lesions. Secondly, the Lu et al. study did not include any patients with 
mild acne vulgaris. This study also focused on adult women with acne and did not include 
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adolescents.  Lastly, the Lu et al. study only lasted for four weeks, while the Elsaie and Ji studies 
lasted six and eight weeks respectively, a longer course.  
 These findings raise the question of whether or not green tea products are better 
treatments in mild to moderate acne, verses severe acne, or more effective in adolescents who 
have an increase in androgens and sebum verses adult women whose pathophysiology behind 
their acne may be more dependent on a different factor.2 Additionally,  it is unknown if six 
weeks of the oral green tea extract would have been as potent as six weeks of topical. None of 
these studies extended beyond two months so more controlled studies would be needed to 
provide a solidified answer as to the efficacy of the proposed treatment.  
 Additionally, EGCG was only isolated in one study, Ji et al., so it is unknown if the 
additional components of green tea used in the other two studies exacerbated or relieved acne as 
opposed to the isolated EGCG. It is also important to note that the exclusion criteria in Elsaie et 
al. and Ji et al. were not made clear and it is unknown if patients had previously been on 
hormonal therapy, isotretinoin, or retinoids and how recently, as well as if they have other 
dermatologic conditions. These factors could all play a role in the results of reductions in lesion 
counts.  
CONCLUSION 
 Acne vulgaris is a condition suffered by millions and though treatments exist there is not 
one best option for all patients with equal efficacy. Effective treatments which focus on all 
factors in the development of acne, such as isotretinoin, do not come without extremely serious 
side effects.4 After a systemic review of two double-blinded RCTs and one case study, it appears 
that the use of the anti-inflammatory polyphenol epigallocatechin-3-gallate in green tea could be 
a potential low-cost, natural alternative medicine for the treatment of acne. With minimal side 
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effects and shown improvement in acne, these green tea products can be an organic option for 
those who want to try a more benign treatment for their acne or to supplement their current 
routine. More research does need to be done, however. Future studies should focus on 1) the best 
formulation and/or administration of the green tea product; 2) which age group and which sex it 
is most effective for; and 3) the effectiveness of longer lengths of treatments. 
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